Gene · 10538
Papers1,963
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,963
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association between pelvic bone marrow dosimetry and acute hematologic toxicity during concurrent chemoradiotherapy for gynecologic malignancies. | J Radiat Res | 2026 | 41536039 | PubTator, text mining | PubMed |
| Single-cell and multi-omic characterization of ex vivo expanded ASTRLs from stable kidney transplant recipients reveals a regulatory T cell phenotype. | Sci Rep | 2026 | 41535376 | PubTator, text mining | PubMed |
| PD-L1 on Tumor-Derived Extracellular Vesicles Induces CD8+ T Cell Terminal Exhaustion and Mediates Anti-PD-1 Resistance in Head and Neck Squamous Cell Carcinoma. | Adv Sci (Weinh) | 2026 | 41194450 | PubTator, text mining | PubMed |
| CD82-associated exhausted CD8+ T cells define prognosis and immunotherapy resistance in colon cancer. | Front Immunol | 2025 | 41607790 | PubTator, text mining | PubMed |
| Rare Structural Variants Uncovered by Optical Genome Mapping in Multisystem Inflammatory Syndrome in Children (MIS-C). | Adv Genet (Hoboken) | 2025 | 41473684 | PubTator, text mining | PubMed |
| Targeting the BATF family in cancer: Tumor-intrinsic signaling and immune microenvironment reprogramming. | Cell Signal | 2025 | 41236002 | PubTator, text mining | PubMed |
| Contextual regulation of T follicular helper cell expansion and differentiation into T regulatory type 1 cells by multiple transcription factors. | Cell Rep | 2025 | 41100252 | PubTator, text mining | PubMed |
| Enhancing anti-tumor immunity by targeting BATF and the STAT1/PD-L1 pathway in cervical carcinoma. | Cell Mol Life Sci | 2025 | 41075009 | PubTator, text mining | PubMed |
| Elucidating biomarkers of carcinogenesis in ulcerative colitis: insight from Mendelian randomization and transcriptomics. | Discov Oncol | 2025 | 41065981 | PubTator, text mining | PubMed |
| Immune system development-related signature predicts prognosis and sorafenib-treatment resistance of hepatocellular carcinoma by intergrating machine learning and single-cell analyses. | Sci Rep | 2025 | 41028204 | PubTator, text mining | PubMed |
| Human precursor T follicular regulatory cells are primed for differentiation into mature Tfr and disrupted during severe infections. | Sci Adv | 2025 | 41004596 | PubTator, text mining | PubMed |
| Continuous DNA Methylation Deconvolution-Based Surrogate for B-Cell Differentiation State in CLL. | bioRxiv | 2025 | 41000815 | PubTator, text mining | PubMed |
| Extrachromosomal circular DNA expressing miRNA promotes ovarian cancer progression. | Clin Transl Med | 2025 | 40984821 | PubTator, text mining | PubMed |
| Mechanisms of Resistance to CAR T-Cells and How to Overcome Them. | Methods Protoc | 2025 | 40981226 | PubTator, text mining | PubMed |
| Regulatory mechanisms of Th9 cell differentiation. | Front Immunol | 2025 | 40948790 | PubTator, text mining | PubMed |
| Integrated Single-Cell RNA-Seq Reveals Immunosuppressive Mechanisms of Treg Cell Differentiation and Tumor Microenvironment Interactions in Colorectal Cancer. | Cancer Med | 2025 | 40891683 | PubTator, text mining | PubMed |
| Key Genes Associated With Functional Specialization of Neonatal Peripheral Monocytes. | Hum Mutat | 2025 | 40874179 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals different cellular states in malignant cells and the tumor microenvironment in primary and metastatic ER-positive breast cancer. | NPJ Breast Cancer | 2025 | 40858590 | PubTator, text mining | PubMed |
| Integrative molecular network analysis of genetic risk factors to infer biomarkers and therapeutic targets for rheumatoid arthritis. | PLoS One | 2025 | 40839671 | PubTator, text mining | PubMed |
| Oncogenic Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus on Cell Metabolism and Cell Transformation. | J Med Virol | 2025 | 40827105 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10538/papers?page=4